TITLE:
A Study of MK0653A (Ezetimibe (+) Simvastatin) in Patients With Hypercholesterolemia (0653A-038)

CONDITION:
Hypercholesterolemia

INTERVENTION:
MK0653A, ezetimibe (+) simvastatin

SUMMARY:

      The purpose of this study is to evaluate the lipid lowering effects of an investigational
      drug in patients with hypercholesterolemia (high cholesterol).
    

DETAILED DESCRIPTION:

      The duration of treatment is 4 months.
    

ELIGIBILITY:
Gender: All
Age: 18 Years to 80 Years
Criteria:

        Inclusion Criteria:

          -  High cholesterol

        Exclusion Criteria:

          -  Patient has a condition which, in the opinion of the investigator, might pose a risk
             to the patient, interfere with participation in the study, or does not meet the
             additional criteria as required by the study.
      
